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Abstract
Purpose: Boron neutron capture therapy (BNCT) is a promising technique for the treatment of malignant disease targeting or-
gans of the human body. Monte Carlo simulations were carried out to calculate optimum design parameters of an accelerator
based beam shaping assembly (BSA) for BNCT of brain cancer setup. Methods: Epithermal beam of neutrons were obtained
through moderation of fast neutrons from 3H(p,n) reaction in a high density polyethylene moderator and a graphite reflector.
The dimensions of the moderator and the reflector were optimized through optimization of epithermal / fast neutron intensity
ratio as a function of geometric parameters of the setup. Results: The results of our calculation showed the capability of our set-
up to treat the tumor within 4 cm of the head surface. The calculated peak therapeutic ratio for the setup was found to be 2.15.
Conclusion: With further improvement in the polyethylene moderator design and brain phantom irradiation arrangement, the
setup capabilities can be improved to reach further deep-seated tumor.
Keywords:BNCT; Brain Phantom; 3H(p,n) Reaction; Polyethylene Moderator and Graphite Reflector; Beam Shaping Assembly;
Monte Carlo simulations
Introduction
Boron neutron capture therapy (BNCT) is a binary radiation
therapy modality proposed as an alternative treatment for
brain tumors.1-9 The two major components of the therapy
are a stable isotope 10B of boron that can be concentrated
preferentially in tumor cells and a beam of low energy neu-
trons.2-3, 8 Initially the BNCT treatment was proposed using
the thermal neutrons beams. Due to low penetrating power
of thermal neutrons it was necessary to open the human
scalp and irradiate the tumor with the thermal neutron
beam. Later it was proposed to use the epithermal neutron
beam, which has enough penetrating power to reach the
deep-seated tumor in the brain without opening the scalp.2, 8
There are several techniques to produce epithermal beams of
neutrons either using nuclear reactors1, 6 or a particle accel-
erator as a neutron source.2-5, 7-9 Epithermal beams of neu-
trons from nuclear reactors have been tested to treat patients
with a glioblastom multiforme, and intracranial metastatic
and subcutaneous melanoma.1, 6 The accelerator based neu-
tron sources have certain advantages over reactor based neu-
tron sources such as low gamma ray background associated
with neutrons, low cost, ease of placing an accelerator in or
near hospitals etc.
An accelerator based beam shaping assembly (BSA) used in
BNCT utilizes fast neutron producing nuclear reaction along
with a moderator-reflector combination to produce desired
features of the neutron beam. It is desired to improve the
quantity and the quality of neutron beams for BNCT treat-
ment by choosing a suitable nuclear reaction in conjunction
with an appropriate moderator-reflector combination. Some
of the nuclear reactions which are tested to produce epi-
thermal neutron beams for BNCT are: 13C(d,n) [4] and 7Li (p,
n).2-5, 7-9 7Li (p, n) reaction is commonly used in conjunction
with different types of moderator-reflector combinations e.g.
light water (H2O) moderator and Alumina (Al2O3) reflector2;
D2O moderator and lead reflector8 and BeO moderator and
Li2CO3 reflector9 etc. to produce epithermal neutron beams.
In this study 3H (p, n) reaction10, 11 was tested for its applica-
tion to produce epithermal neutrons beam for BNCT appli-
cation. 3H (p, n) reaction is similar to 7Li (p, n) reaction but
with slightly higher neutron energy than those from 7Li (p,
n) reaction.12 The neutrons from 3H (p, n) reaction have keV
energies, and are moderated in a high density polyethylene
moderator and then are collimated to a brain phantom con-
taining boron concentrated tissues. This paper describes the
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design calculation of the moderator assembly and ultimate
dose in the brain phantom.
Methods and Materials
BNCT geometry
The geometry of the 3H(p,n) reaction based BNCT setup is
shown in Figure 1. It mainly consists of a 3H(p,n) point
source located inside a cylindrical polyethylene moderator.
A graphite reflector is built around the moderator to en-
hance the epithermal neutron yield. A double truncated
cylindrical collimator was used to collimate the epithermal
neutron beam from the moderator to the tumor location in
the brain phantom.13 The collimator was made of paraffin
and lithium carbonate mixed in equal weight fractions. The
BNCT setup geometry was optimized by calculating the epi-
thermal, thermal and fast neutron intensities as a function of
moderator size, reflector size and source position inside the
moderator. The neutron dose in the boron carrying tumor in
the brain phantom was calculated. Due to its high hydrogen
concentration and easy machining properties, high-density
polyethylene was chosen as the moderator material. The
number of particles used in this study was 1E09; this number
of histories gave 1.34% of uncertainty.
Neutron energy spectrum from 3H(p,n) reaction
3H(p,n) reaction near the reaction threshold was used to
produce fast neutrons. The neutrons from the 3H(p,n) reac-
tion near the reaction threshold are emitted in a forward
cone with a maximum energy ranging up to few hundred
keV.10, 11 The neutrons are not mono-energetic and they have
an energy distribution of Maxwellian type and the experi-
mental angular distribution data can be fitted with an ana-
lytical function of type: Ee-E/kT. The best fit is obtained for
neutrons produced by a proton beam with energy 80 keV
above the reaction threshold. The experimental neutron
spectrum has a 91% overlap with a Maxwellian distribution
for kT=52 keV and the neutrons are emitted within an angu-
lar cone of ± 60° with respect to the proton beam axis.11 The
neutron energy spectrum, used in this study, was generated
using a built-in neutron source function of the MCNP4B2
code for an evaporation energy spectrum of the type: Ee(-E/a)
with a = 0.052 MeV.14, 15
Brain phantom
The human brain and its surrounding structures were mod-
eled using the MCNP transport code. The data used to model
human brain and its surrounding structures were taken from
reference.10 As shown in Figure 2, the brain is assumed to be
an ellipsoid with axes 132, 172 and 115 mm respectively; and
is surrounded by a skull of thickness 9 mm, and a scalp con-
sisting of soft tissue (3 mm) and skin (2 mm). The elemental
compositions of the material present in the cranium are
listed in the Table 1. The data were taken from ICRU-44.16
The dose was evaluated in volume segments around the cen-
tral axis of the neutron beam. The dose profiles were ob-
tained by extrapolating to the central axis. The boron con-
centrations in different parts of the phantom are listed in the
Table 2.
FIG. 1: Schematic of accelerator-based BNCT setup.
FIG. 2: Schematic of the brain phantom used for dose calculations.
TABLE 1: Elemental composition of brain and skull Phantom taken
from IRCU 7.
Phantom part Boron concentration(g/g)
Skin 15
Tissue under skin 10
Skull −
Normal brain tissue 10
Tumor brain tissue 35
Volume 3 • Number 3 • 2015 International Journal of Cancer Therapy and Oncology 3
www.ijcto.org
© Elshahat et al. ISSN 2330-4049
TABLE 2: Boron Concentration in Brain.
Parameters Values
Moderator thickness (cm) 9 cm
Source position (cm) 4 cm from the modera-
end facing brain phan-
tom
Moderator outer radius (cm) 4
Graphite side reflector thickness
(cm)
2-3
γ-ray Pb side shielding thickness
(cm)
0.5
γ-ray Pb front shielding thickness
(cm)
0.2
Neutrons side shielding thickness
(cm)
0.5-1.0 cm
The therapeutic efficacy of neutron beams for our BNCT
setup were calculated through its figures-of –Merit i.e. Ad-
vantage depth (AD), Advantage ratio (AR), and Peak thera-
peutic ratio.1 The AD indicates the penetrability of the neu-
tron beam while AR gives the tumor dose relative to sur-
rounding healthy tissue dose; and the peak therapeutic ratio
gives maximum tumor dose / maximum healthy tissue dose
ratio.2 The advantage depth is defined as the depth in a
phantom at which point the tumor dose rate equals the
maximum healthy tissue dose rate. Any tumor mass located
beyond the AD receives less than the maximum healthy
tissue dose, thus reducing any treatment ‘‘advantage.’’ The
advantage ratio is defined as the ratio of the areas under the
dose rate curves for tumor and healthy tissue along the
phantom centerline from the surface to the advantage
depth2:
= ∫ ( )∫ ( )
Where, Dtumor(z) and Dtissue(z) are the doses to tumor and
healthy tissue, respectively, along the centerline (z-axis) of
the phantom.2 Finally, the advantage depth dose rate is de-
fined as the tumor dose rate at the advantage depth, which is
equal to the maximum healthy tissue dose rate. In all dosim-
eteric calculations of biological systems, dose components
should be weighted with appropriate relative biological ef-
fectiveness (RBE) factors.
The following RBE values are used for the dose components
in these BNCT simulations: fast neutron, 3.2; thermal neu-
tron, 3.2; 10B in healthy tissue, 1.35; 10B in tumor, 3.8; pho-
ton, 1.0 photon.2 Currently, these RBE values are being used
in clinical BNCT trials at the Massachusetts Institute of
Technology (MIT) and Brookhaven National Laboratory
(BNL) along with the pharmaceutical borono-phenylalanine
(BPA) as the boron delivery compound. Dosimeteric conver-
sion factors and 10B concentrations followed generally ac-
cepted standards when using BPA for brain glioma’s.2 Any
adjustment of these RBE values will change all three figures
of merit defined above, and inter-comparisons of the results
presented here with published results for other neutron
beams must take this into account. It should be noted that
tumor and healthy tissue boron RBE values are unlikely to
differ between reactor and near-threshold beams, since they
are primarily determined by the distribution of the boron
compound within cells.17
However, the neutron RBE values for near-threshold beams
may differ appreciably from those for reactor beams, because
the neutron energy spectra of reactor and near-threshold
beams differ. Since RBE values for near threshold neutron
energy spectra of have not been determined, the RBE values
given above are considered at this point a ‘‘best guess’’ and
are used for comparison purposes only.
Results and Discussion
BNCT setup geometry optimization
The BNCT setup geometry was optimized by calculating
epithermal, thermal and fast neutron intensities as a function
of moderator length and radius, reflector size and source
position inside the moderator. For all moderator lengths, the
epithermal neutron yield increases initially with increasing
distance of the source from the moderator-end facing the
brain phantom and then decreases rapidly. As shown in the
Figure 3, the maximum yield of the epithermal neutrons has
been observed for the source position at a distance of 0.75 cm
from the moderator-end facing the brain phantom. The fast
neutron intensity decreases very rapidly with increasing
source distance inside the moderator. This is clearly shown
in Figure 4, which represents epithermal and fast neutron
yield as a function of source position inside 2-14 cm long
polyethylene moderators.
In the Figures 3 and 4 each curve terminates at maximum
length of corresponding moderator. For all moderator
lengths, the maximum value of epithermal/ fast neutron
yield ratio was observed for a source position at a distance of
4 cm from the moderator end facing the brain phantom.
Figure 5 represents epithermal/fast neutron yield ratio and
epithermal /thermal neutron yield ratio plotted as a function
of 3-15 cm long moderators. Both ratios show almost con-
stant values for moderator lengths in excess of 9 cm. There-
fore, a 9 cm long moderator with a neutron source located at
a distance of 4 cm from the moderator end was chosen to be
an optimum moderator length. Similarly, for modera-
tor-radius optimization, an epithermal/fast and epither-
mal/thermal neutrons intensities ratios were calculated as a
function of the moderator radius. As shown in Figure 6, the
optimum value of the two ratios can be achieved with a
moderator having 4 cm radius.
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FIG. 3: Epithermal neutron yield as a function of source position
inside a 2-14 cm long polyethylene moderator. Each curve termi-
nates at maximum length of corresponding moderator.
FIG. 4: Epithermal/ Fast neutrons yield ratio plotted as a function of
source position inside a 2-14 cm long moderators. Each curve ter-
minates at maximum length of corresponding moderator.
FIG. 5: Optimum Epithermal/fast and epithermal /thermal neutrons
ratio plotted as a function of 3-15 cm long moderators.
FIG. 6: Optimum Epithermal/fast neutrons ratio plotted as a func-
tion of moderator radius.
FIG. 7: Optimum Epithermal/fast and epithermal /thermal neutrons
ratio plotted as a function of side graphite reflector thickness.
The reflector thickness was then optimized using the ratios
of epithermal/fast and epithermal/thermal neutron intensi-
ties calculated as a function of graphite reflector thickness.
Since the reflector increases the intensity of thermal neu-
trons, the epithermal/thermal ratio decreases rapidly with
increasing reflector collar. As a compromise between the
two ratios, as shown in Figure 7, 2-3 cm thick graphite re-
flector was found to be optimum. Neutron shielding using
Paraffin and Li2CO3 and gamma ray lead shielding was built
around the moderator and its cylindrical graphite reflector to
minimize the dose at the brain phantom outside the field of
treatment.
The neutron intensity was found to be reduced by 50% after
using 5 mm thickness of the paraffin absorber. The γ-rays are
attenuated by only 5% in the same thickness of the paraffin.
In order to reduce the gamma ray dose at the brain phantom
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location, a 5 mm thick lead shielding was inserted at the exit
of the moderator assembly. The length of the neutron colli-
mator was assumed to be 2-3 times the neutrons mean free
path. The collimator length used in the simulation was 50
cm. The optimum values of the geometry parameters of the
BSA are listed in Table 3.
TABLE 3: Optimum values of the design parameters of the accelerator based BNCT setup.
Mat. Z/A I(eV) Density Brain phantom composition in weight fraction given in term of atomic number Z
Z=1 Z=6 Z=7 Z=8 Z=11 Z=12 Z=15 Z=16 Z=17 Z=19 Z=20
Skin 0.54975 74.9 1.000 0.1011 0.111 0.026 0.762
Soft 0.54996 74.7 1.06 0.102 0.143 0.034 0.708 0.002 - 0.003 0.003 0.002 0.003
Tissue
Skull 0.51478 112.0 1.92 0.034 0.155 0.042 0.435 0.001 0.002 0.103 0.003 0.225
Brain 0.55239 73.9 1.04 0.107 0.145 0.022 0.712 0.002 - 0.004 0.002 0.003 0.003
FIG. 8: Calculated neutron, boron and photon dose in tumor, and healthy tissues at different depth of cranium.
TABLE 4: Comparison of figure of merit of various BNCT setups.
Exp-Design Reaction Moderator/Reflector RBE-AD RBE-ADDR
YZSK [8 ] 7Li(p,n) D2O/Pb 8.5 4.1
WBGG[9 ] 7Li(p,n) BeO/Li2CO3 9.2 5.0
LZKHH[ 2] 7Li(p,n) H2O/Al2O3 5.9 4.8
Present study 3H(p,n) Polyethylene/Graphite 4
Dose calculations in a brain phantom
Figure 8 shows the calculated neutron and photon doses in
the tumor and healthy tissues at different depth of the cra-
nium. The neutron dose is almost zero at the location of the
skin, soft tissue and skull that has almost no Boron uptake.
The neutron dose increases as the depth in brain tissue in-
creases, it reaches a maximum and then decreases. At the
depth of maximum neutron dose in the tumor tissue, the
neutron dose to healthy tissue is about half of that of the
tumor tissue.18 The photon dose calculated in the phantom
does not include the gamma ray dose associated with 3H(p,
n) reaction. It only includes gamma rays from the moderator
setup and the phantom itself. The value of advantage depth
AD (RBE-AD) obtained in our study is 4 cm. The value of
advantage ratio (AR) was found to be 1.92. The Peak thera-
peutic ratio calculated was found to be 2.15. The results ob-
tained in the present study are listed in Table 4 along with
the results quoted for other accelerator-based facilities in
reference.2
The values of RBE-AD and AR are very specific to set up
design parameters such as moderator material, reflector ma-
terial, and irradiation setup of brain phantom. As shown in
Table 4, the YZSK 8 and WBGG 9 designs have superior
RBE-ADs, and therefore can treat deeper tumor than the
near-threshold design. RBE-ADDR (advantage depth
dose rates) values are listed in Table 4. The RBE-AR from
LZKHH 2, YZSK and WBGG studies are comparable. The
three setups use different moderator/reflector combinations
and geometries. The LZKHH setup has an annulus of D2O for
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neutron shielding. In WBGG design, the patient head is
placed inside the inner radius of the D2O shield. The YZSK
design uses a D2O/6Li neutron shield surrounding the reflec-
tor. The LZKHH design utilizes Li (p, n) reaction while
YZSK design uses Li (p, n) reaction with 2.5 MeV protons to
produce neutrons. Our design which uses 3H(p, n) reaction at
the threshold energy gives result closer to LZKHH design.
Replacing the moderator with more appropriate one and
choosing more effective irradiation arrangement of the brain
phantom, can improve RBE-AD and AR. of our setup.
Conclusion
A systematic study has been carried out to design an acceler-
ator based BNCT setup using 3H(p, n) reaction near thresh-
old. In the calculation the moderator, reflector and collima-
tors size was optimized. Finally neutron dose was calculated
at a tumor location in a brain phantom. Results of our calcu-
lation showed the capability of our setup to treat the tumor
within 4 cm of the head surface. With further improvement
in the design and brain sample irradiation arrangement, the
setup capabilities can be improved to reach deeper seated
tumor.
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